NexgenRx, Inc. (NXG.V)
0.33
-0.02
(-5.71%)
CAD |
TSXV |
Feb 11, 16:00
NexgenRx Shareholders Equity (Quarterly) : 8.289M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cronos Group, Inc. | 1.506B |
| Cannara Biotech, Inc. | 111.21M |
| Medexus Pharmaceuticals, Inc. | 72.93M |
| Arch Biopartners, Inc. | -3.882M |
| Biocure Technology, Inc. | 1.604M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 39.20M |
| Total Liabilities (Quarterly) | 30.91M |
| Debt to Equity Ratio | 0.0501 |
| Current Ratio | 1.108 |
| Net Debt Paydown Yield | 0.05% |